Annual Operating Profit
-$16.89 M
+$14.80 M+46.70%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual operaing income is currently -$16.89 million, with the most recent change of +$14.80 million (+46.70%) on 31 December 2023. During the last 3 years, it has risen by +$24.07 million (+58.77%).ACRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$4.28 M
-$974.00 K-29.43%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly operating income is currently -$4.28 million, with the most recent change of -$974.00 thousand (-29.43%) on 31 December 2023. Over the past year, it has dropped by -$974.00 thousand (-29.43%).ACRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$16.89 M
+$3.10 M+15.52%
31 December 2023
Summary:
AcelRx Pharmaceuticals TTM operating income is currently -$16.89 million, with the most recent change of +$3.10 million (+15.52%) on 31 December 2023. Over the past year, it has increased by +$3.10 million (+15.52%).ACRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.7% | -29.4% | +15.5% |
| 3 y3 years | +58.8% | +50.4% | +54.4% |
| 5 y5 years | +52.7% | +68.3% | +66.3% |
ACRX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +153.3% | -121.4% | +405.5% |
AcelRx Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$16.89 M(-46.7%) | -$4.28 M(+29.4%) | -$16.89 M(-15.5%) |
| Sept 2023 | - | -$3.31 M(-16.6%) | -$19.99 M(-14.3%) |
| June 2023 | - | -$3.97 M(-25.5%) | -$23.32 M(-4.4%) |
| Mar 2023 | - | -$5.33 M(-27.9%) | -$24.40 M(+1.6%) |
| Dec 2022 | -$31.68 M(-11.9%) | -$7.39 M(+11.4%) | -$24.01 M(-3.2%) |
| Sept 2022 | - | -$6.63 M(+31.2%) | -$24.80 M(-7.5%) |
| June 2022 | - | -$5.05 M(+2.4%) | -$26.80 M(-15.6%) |
| Mar 2022 | - | -$4.94 M(-39.6%) | -$31.76 M(-11.7%) |
| Dec 2021 | -$35.97 M(-12.2%) | -$8.18 M(-5.3%) | -$35.97 M(-2.9%) |
| Sept 2021 | - | -$8.63 M(-13.8%) | -$37.03 M(-1.1%) |
| June 2021 | - | -$10.02 M(+9.5%) | -$37.44 M(+9.3%) |
| Mar 2021 | - | -$9.14 M(-1.1%) | -$34.26 M(-16.4%) |
| Dec 2020 | -$40.96 M(-24.4%) | -$9.24 M(+2.3%) | -$40.96 M(-12.3%) |
| Sept 2020 | - | -$9.04 M(+32.2%) | -$46.71 M(-8.8%) |
| June 2020 | - | -$6.83 M(-56.9%) | -$51.21 M(-11.3%) |
| Mar 2020 | - | -$15.85 M(+5.7%) | -$57.73 M(+6.5%) |
| Dec 2019 | -$54.20 M(+51.7%) | -$14.99 M(+10.8%) | -$54.20 M(+8.0%) |
| Sept 2019 | - | -$13.53 M(+1.3%) | -$50.19 M(+9.1%) |
| June 2019 | - | -$13.36 M(+8.5%) | -$45.98 M(+15.6%) |
| Mar 2019 | - | -$12.32 M(+12.2%) | -$39.78 M(+11.3%) |
| Dec 2018 | -$35.73 M(-7.6%) | -$10.98 M(+17.7%) | -$35.73 M(+9.7%) |
| Sept 2018 | - | -$9.33 M(+30.4%) | -$32.56 M(+1.5%) |
| June 2018 | - | -$7.15 M(-13.5%) | -$32.09 M(-8.0%) |
| Mar 2018 | - | -$8.27 M(+5.9%) | -$34.88 M(-9.8%) |
| Dec 2017 | -$38.68 M(+21.0%) | -$7.81 M(-11.9%) | -$38.68 M(+1.8%) |
| Sept 2017 | - | -$8.86 M(-10.9%) | -$38.01 M(+2.4%) |
| June 2017 | - | -$9.94 M(-17.7%) | -$37.13 M(+4.6%) |
| Mar 2017 | - | -$12.07 M(+69.1%) | -$35.51 M(+11.1%) |
| Dec 2016 | -$31.96 M | -$7.14 M(-10.5%) | -$31.96 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$7.97 M(-4.2%) | -$32.35 M(+87.3%) |
| June 2016 | - | -$8.32 M(-2.3%) | -$17.27 M(+1.2%) |
| Mar 2016 | - | -$8.52 M(+13.1%) | -$17.07 M(-11.1%) |
| Dec 2015 | -$19.20 M(-49.0%) | -$7.54 M(-206.1%) | -$19.20 M(-18.1%) |
| Sept 2015 | - | $7.11 M(-187.5%) | -$23.44 M(-34.2%) |
| June 2015 | - | -$8.12 M(-23.7%) | -$35.62 M(-10.4%) |
| Mar 2015 | - | -$10.65 M(-9.6%) | -$39.75 M(+5.6%) |
| Dec 2014 | -$37.65 M(+464.7%) | -$11.78 M(+132.4%) | -$37.65 M(+539.5%) |
| Sept 2014 | - | -$5.07 M(-58.7%) | -$5.89 M(-35.5%) |
| June 2014 | - | -$12.26 M(+43.5%) | -$9.13 M(+96.8%) |
| Mar 2014 | - | -$8.54 M(-142.7%) | -$4.64 M(-30.4%) |
| Dec 2013 | -$6.67 M(-77.6%) | $19.98 M(-340.5%) | -$6.67 M(-80.8%) |
| Sept 2013 | - | -$8.31 M(+6.9%) | -$34.68 M(+0.3%) |
| June 2013 | - | -$7.77 M(-26.5%) | -$34.56 M(+2.4%) |
| Mar 2013 | - | -$10.57 M(+31.6%) | -$33.74 M(+13.5%) |
| Dec 2012 | -$29.71 M(+53.5%) | -$8.03 M(-2.0%) | -$29.71 M(+8.1%) |
| Sept 2012 | - | -$8.19 M(+17.9%) | -$27.48 M(+11.3%) |
| June 2012 | - | -$6.95 M(+6.1%) | -$24.69 M(+10.4%) |
| Mar 2012 | - | -$6.55 M(+13.0%) | -$22.36 M(+15.6%) |
| Dec 2011 | -$19.35 M(+58.8%) | -$5.79 M(+7.2%) | -$19.35 M(+18.0%) |
| Sept 2011 | - | -$5.41 M(+17.0%) | -$16.40 M(+20.6%) |
| June 2011 | - | -$4.62 M(+30.7%) | -$13.60 M(+10.7%) |
| Mar 2011 | - | -$3.54 M(+24.3%) | -$12.29 M(+0.8%) |
| Dec 2010 | -$12.19 M(-36.0%) | -$2.84 M(+9.2%) | -$12.19 M(-3.9%) |
| Sept 2010 | - | -$2.60 M(-21.3%) | -$12.69 M(+25.8%) |
| June 2010 | - | -$3.31 M(-3.6%) | -$10.08 M(+48.8%) |
| Mar 2010 | - | -$3.43 M(+2.8%) | -$6.77 M(+102.8%) |
| Dec 2009 | -$19.03 M(-8.0%) | -$3.34 M | -$3.34 M |
| Dec 2008 | -$20.69 M | - | - |
FAQ
- What is AcelRx Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals annual operating profit year-on-year change?
- What is AcelRx Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly operating profit year-on-year change?
- What is AcelRx Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals TTM operating profit year-on-year change?
What is AcelRx Pharmaceuticals annual operaing income?
The current annual operating profit of ACRX is -$16.89 M
What is the all time high annual operating profit for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual operaing income is -$6.67 M
What is AcelRx Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ACRX annual operaing income has changed by +$14.80 M (+46.70%)
What is AcelRx Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ACRX is -$4.28 M
What is the all time high quarterly operating profit for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly operating income is $19.98 M
What is AcelRx Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ACRX quarterly operating income has changed by -$974.00 K (-29.43%)
What is AcelRx Pharmaceuticals TTM operating income?
The current TTM operating profit of ACRX is -$16.89 M
What is the all time high TTM operating profit for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high TTM operating income is -$3.34 M
What is AcelRx Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ACRX TTM operating income has changed by +$3.10 M (+15.52%)